What should I Know Regarding Pregnancy, Nursing and Administering Sumatriptan Succinate to Children or the Elderly?
If you are PREGNANT
- Only When Necessary: INSUFFICIENT HUMAN DATA; ANIMAL DATA SUGGEST DEVELOPMENTAL TOXICITY
If you are NURSING
- Precaution: LOW LEVELS EXCRETED; MFR SUGGESTS DELAYING NURSING FOR 12 HOURS AFTER DOSE
If you are an adult over 60
- management or monitoring precaution: Hepatic-Elderly patients are more likely to have decreased hepatic function thus decreasing drug clearance. Cardiovascular-Hypertensive effects may be more pronounced in the elderly and increase the risk for cardiovascular events in those with cardiovascular disease. A cardiovascular evaluation is recommended in those with CV risk factors, Avoid use of the drug in any patient with a cerebrovascular syndrome.
Giving Sumatriptan Succinate to a child under 12
- Severe Precaution: Efficacy not established over placebo for treatment of migraine. Adverse event risk similar to adults including visual loss and stroke.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.